NODE 301 PSVT: The primary objective of this study is to determine whether etripamil nasal spray (NS) 70 mg is superior to placebo at terminating episodes of PSVT in an outpatient setting.
The secondary objective of this study is to evaluate the safety of etripamil NS 70 mg when administered without medical supervision
Primary Investigator: Sean Mazer, MD, FHRS, FACC
Michael Bestawros, MD, MPH
Yaw Adjei-Poku, MD
Brad Gwyther, MS, PA-C
Laura McDermott, CNP, MSN, CACP